Ligand validation:3PB5

F63: N-methyl-1-[5-(pyridin-3-yloxy)furan-2-yl]methanamine

F63 is a Ligand Of Interest in 3PB5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PB5_F63_A_1001	57%	53%	0.116	0.891	1.14	0.68	2	-	0	0	100%	1
4Y57_F63_A_404	95%	44%	0.068	0.972	1.26	0.93	2	1	0	0	100%	1
5MB0_F63_A_342	54%	42%	0.141	0.905	1.34	0.92	2	1	2	0	100%	0.68
6ZZ2_F63_A_401	68%	41%	0.105	0.917	1.21	1.08	2	1	0	0	100%	0.86
6FSO_F63_A_406	33%	53%	0.148	0.826	1.2	0.63	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.